Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Operating Expenses | 72,347 | 26,778 |
| Operating Income | -72,347 | -26,778 |
| Interest Expense | 0 | 585 |
| Other Income | 2,352 | 875 |
| Pre-tax Income | -69,995 | -26,488 |
| Net Income Continuous | -69,995 | -26,488 |
| Net Income | $-69,995 | $-26,488 |
| EPS Basic Total Ops | -111.91 | -37.05 |
| EPS Basic Continuous Ops | -93.95 | -35.94 |
| EPS Diluted Total Ops | -111.91 | -37.05 |
| EPS Diluted Continuous Ops | -93.95 | -35.94 |
| EBITDA(a) | $-72,347 | $-26,778 |